About Premature Ejaculation
Premature ejaculation is a common sexual dysfunction in men, which is characterized by early discharge of semen. Premature ejaculation can be diagnosed through IELT, which is the average time taken by a man to ejaculate during sexual intercourse. There are two types of premature ejaculation: Primary premature ejaculation and secondary premature ejaculation.
TechNavio's analysts forecast the Global Premature Ejaculation market to grow at a CAGR of 10.20 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Premature Ejaculation market for the period 2014–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of premature ejaculation that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Premature Ejaculation market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market at large.
TechNavio's report, the Global Premature Ejaculation Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC and EMEA regions; it also covers the Global Premature Ejaculation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Absorption Pharmaceuticals
• Furiex Pharmaceuticals
• Innovus Pharmaceuticals
• Plethora Solutions
Other Prominent Vendors
• Bayer
• Dong-A Pharmaceutical
• Dong-A ST
• Eli Lilly
• Emcure
• Endo
• Futura Medical
• GlaxoSmithKline
• Medisyn
• Menarini
• NeuroHealing
• Pfizer
• Shionogi
• Symyoo
• Vectura
• Vyrix
Market Driver
• Presence of Unmet Need
• For a full, detailed list, view our report
Market Challenge
• Unknown Etiology
• For a full, detailed list, view our report
Market Trend
• Rise in Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Product Profiles
04.1 Promescent
04.2 Priligy
04.3 EjectDelay
04.4 Tempe
05. Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06. Introduction
07. Disease Overview and Management
07.1 Disease Overview
07.1.1 Disease Classification
07.1.2 Epidemiology
07.2 Management of Premature Ejaculation
07.2.1 Diagnosis
07.2.2 Management of Premature Ejaculation
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by Route of Administration
09.1 Oral
09.2 Topical
10. Market Segmentation by Dosage Form
10.1 Solid
10.2 Liquid
10.3 Semi-solid
11. Market Segmentation by Mechanism of Action
11.1 SSRI
11.2 Amide Anesthetics
11.3 PDE5 Inhibitors
12. Geographical Segmentation
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2013
20.3 Other and Future Prominent Vendors
21. Pipeline Portfolio
21.1 Key Information about the Pipeline Drugs
22. Key Vendor Analysis
22.1 Absorption Pharmaceuticals
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 SWOT Analysis
22.2 Furiex
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Strategy
22.2.4 SWOT Analysis
22.3 Innovus
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Strategy
22.3.4 SWOT Analysis
22.4 Plethora Solutions
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 SWOT Analysis
23. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Recommendations to Diagnose Premature Ejaculation
Exhibit 3: Global Premature Ejaculation Market 2013-2018 (US$ million)
Exhibit 4: Global Premature Ejaculation Market Segmentation by Route of Administration
Exhibit 5: Global Premature Ejaculation Market Segmentation by Route of Administration
Exhibit 6: Global Premature Ejaculation Market Segmentation by Dosage Form
Exhibit 7: Global Premature Ejaculation Market Segmentation by Dosage Form
Exhibit 8: Global Premature Ejaculation Market Segmentation by Mechanism of Action
Exhibit 9: Global Premature Ejaculation Market Segmentation by Mechanism of Action
Exhibit 10: Global Premature Ejaculation Market by Geographical Segmentation
Exhibit 11: Snapshot of the Pipeline Drugs for Premature Ejaculation
